Cardiology

Results of the LINK-HF study indicate a wearable sensors from Vital Connect combined with a predictive algorithm can predict HF exacerbations.

A fourth-year medical student discusses strategies for anticoagulation reversal in intensive care units from a presentation during the 49th Annual Critical Care Congress in Orlando.

New data from a study of 30 patients found specific characteristics of gut microbiota could predict the presence of pulmonary hypertension with greater than 80% accuracy.

With approval, the GLP-1 receptor agonist becomes the first diabetes drug approved for reducing MACE in patients with and without established cardiovascular.

The approval of bempedoic acid (Nexletol) marks the first oral, non-statin therapy approved by the FDA as a lipid-lowering agent in nearly 20 years.

Clinical trial data for the lipid-lowering non-statin agent indicates it can lower LDL-C by as much as 18% when combined with maximally tolerated statins.

A secondary analysis of patients with prior stroke, TIA, or thromboembolism from AUGUSTUS is revealing more about the use of apixaban in patients with AFib.

New data indicates a combination of 3 natural extracts added to standard therapy could provide benefits in patients with uncontrolled hypertension.

Varenicline should be considered as a treatment option for smoking cessation, the findings suggest.

An analysis of the French cohort from the TST trial was presented during ISC 2020 in Los Angeles, CA.

A look back on the biggest discussions of the 29th Annual Cardiovascular Conference in Beaver Creek, CO.

A pair of colleagues from Duke detail what makes the annual cardiovascular meeting beneficial to researchers and clinicians.

Research from the Karolinska Institute indicates ESC/EAS 2019 dyslipidemia guidelines could create an unforeseen financial burden due to new eligibility for PSCK9 class.

A new analysis is revealing more about how using a patient portal can aid in medication adherence and HbA1c management among diabetics.

New data on the use of polygenic risk scores for predicting certain forms of cardiovascular disease raise questions about the validity of genetic scores in real-world settings.

A fourth-year medical student offers perspective on a study examining machine learning models being presented at CCC 49 in Orlando, FL as part of HCPLive's Notes from Rounds program.

Analysis using data from the Nurses' Health Study is shedding new light on the interaction of TMAO and coronary heart disease risk.

A new study from the Columbia University Irving Medical Center found another diuretic appeared to have less serious side effects than the guideline-recommended chlorthalidone.

Findings of a recent study may help providers make more informed treatment recommendations for patients with reduced blood flow.

A study from Rutgers University is shedding more light on the additional cardiovascular risk among preeclamptic women.

A new study based on a pair of Chinese studies links depression to all-cause mortality in men more than women.

A pilot study found consumption of cocoa and epicatechin were linked to improved six-minute walking time in PAD patients.

A review of trials from more than 100 cancer drugs found almost 40% did not report any cardiovascular disease outcomes.

Data from the TAUSSIG study supports the long-term use of evolocumab for the treatment of both phenotypes of hypercholesterolemia.

Understanding the accuracy of wearables can help inform better medical decisions, investigators say.